Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Ultra low dose interleukin-2 therapy promotes a type I cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies
Vijay P. Khatri
,
Todd A. Fehniger
, Robert A. Baiocchi
, Feng Yu
, Manisha H. Shah
, Daryl S. Schiller
, Margaret Gould
, Ricardo T. Gazzinelli
, Zale P. Bernstein
, Michael A. Caligiuri
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Section of Stem Cell Biology
DBBS - Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
56
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Ultra low dose interleukin-2 therapy promotes a type I cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cytokine Profile
100%
Ultra-low Dose
100%
IL-1 Family Cytokines
100%
Low-dose interleukin-2
100%
Non-AIDS Events
100%
Interleukin-2
40%
Low-dose IL-2
40%
Gene Expression
20%
Host Immune Response
20%
Protein Production
20%
Quantitative PCR
20%
Type I IFN
20%
PCR Assay
20%
CD8+ T Cells
20%
Endogenous Genes
20%
Infectious Agents
20%
Endogenous Production
20%
Subcutaneous Administration
20%
Infectious Pathogens
20%
Immunodeficient
20%
Expanded Natural Killer Cells
20%
Endogenous Types
20%
IL-2 Therapy
20%
Immunology and Microbiology
Cytokine
100%
Low Drug Dose
100%
Interleukin 2
100%
Infectious Agent
33%
Natural Killer Cell
16%
Gene Expression
16%
Host Immune Response
16%
Cytotoxic T-Cell
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Extract
16%
In Vitro
16%